Article 5(5) of Regulation (EU) 2021/953 was also amended by Regulation (EU) 2022/1034 in order to allow Member States to issue vaccination certificates to participants in clinical trials that have been approved by Member States’ ethical committees and competent authorities, regardless of whether the participant received the COVID-19 vaccine candidate or, to avoid undermining the studies, the dose administered to the control group. Pursuant to Article 3(11) of Regulation (EU) 2021/953, where necessary, the Commission is to ask the Health Security Committee, ECDC or EMA to issue guidance on the acceptance of COVID-19 vaccines undergoing clinical trials in the Member States.
Recital 5, Decision_act (EU) 2022/1516
In forcesince 8 Sep 2022
- celex=32021R0953